Canaccord Genuity Reiterates a 'Buy' on GenMark Diagnostics (GNMK); Secondary Completed
Tweet Send to a FriendGet Alerts GNMK Hot Sheet
Price: $9.57 -12.76%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade GNMK Now!
Canaccord Genuity reiterates a 'Buy' on GenMark Diagnostics (NASDAQ: GNMK) price target of $12.00.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on shares of GNMK after the company recently completed a secondary offering to support its Next-Gen strategy. GNMK issued 10M shares of common stock with net proceeds of approximately $39.3M...We reduced our loss per share estimate to reflect the recent offering
and higher share count."
For an analyst ratings summary and ratings history on GenMark Diagnostics click here. For more ratings news on GenMark Diagnostics click here.
Shares of GenMark Diagnostics closed at $4.34 yesterday, with a 52 week range of $3.63-$6.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jeffrey Frelick, said, "We reiterate our rating on shares of GNMK after the company recently completed a secondary offering to support its Next-Gen strategy. GNMK issued 10M shares of common stock with net proceeds of approximately $39.3M...We reduced our loss per share estimate to reflect the recent offering
and higher share count."
For an analyst ratings summary and ratings history on GenMark Diagnostics click here. For more ratings news on GenMark Diagnostics click here.
Shares of GenMark Diagnostics closed at $4.34 yesterday, with a 52 week range of $3.63-$6.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Terex (TEX) Suffers from Weakness in Europe; Read-Through For Manitowoc (MTW)
- Wedbush Starts Intuitive Surgical (ISRG) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
